Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of GBP 135.50 billion. The enterprise value is 169.67 billion.

Market Cap	135.50B
Enterprise Value	169.67B

Important Dates

The next confirmed earnings date is Thursday, April 30, 2026.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	Feb 13, 2026

Share Statistics

Current Share Class	539.69M
Shares Outstanding	n/a
Shares Change (YoY)	+0.19%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	0.17%
Owned by Institutions (%)	81.91%
Float	538.24M

Valuation Ratios

The trailing PE ratio is 23.65 and the forward PE ratio is 15.16.

PE Ratio	23.65
Forward PE	15.16
PS Ratio	4.96
PB Ratio	21.06
P/TBV Ratio	n/a
P/FCF Ratio	22.51
P/OCF Ratio	18.31
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.63, with an EV/FCF ratio of 28.19.

EV / Earnings	29.62
EV / Sales	6.26
EV / EBITDA	13.63
EV / EBIT	19.86
EV / FCF	28.19

Financial Position

The company has a current ratio of 1.14, with a Debt / Equity ratio of 6.40.

Current Ratio	1.14
Quick Ratio	0.73
Debt / Equity	6.40
Debt / EBITDA	3.29
Debt / FCF	6.84
Interest Coverage	3.66

Financial Efficiency

Return on equity (ROE) is 106.10% and return on invested capital (ROIC) is 18.12%.

Return on Equity (ROE)	106.10%
Return on Assets (ROA)	7.93%
Return on Invested Capital (ROIC)	18.12%
Return on Capital Employed (ROCE)	17.78%
Weighted Average Cost of Capital (WACC)	6.36%
Revenue Per Employee	866,857
Profits Per Employee	181,882
Employee Count	31,500
Asset Turnover	0.40
Inventory Turnover	1.62

Taxes

In the past 12 months, Amgen has paid 939.90 million in taxes.

Income Tax	939.90M
Effective Tax Rate	14.09%

Stock Price Statistics

The stock price has increased by +22.64% in the last 52 weeks. The beta is 0.47, so Amgen's price volatility has been lower than the market average.

Beta (5Y)	0.47
52-Week Price Change	+22.64%
50-Day Moving Average	361.02
200-Day Moving Average	323.47
Relative Strength Index (RSI)	42.14
Average Volume (20 Days)	1,749

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.69

Income Statement

In the last 12 months, Amgen had revenue of GBP 27.31 billion and earned 5.73 billion in profits. Earnings per share was 10.57.

Revenue	27.31B
Gross Profit	19.33B
Operating Income	8.60B
Pretax Income	6.67B
Net Income	5.73B
EBITDA	12.35B
EBIT	8.60B
Earnings Per Share (EPS)	10.57

Balance Sheet

The company has 6.78 billion in cash and 41.19 billion in debt, giving a net cash position of -34.41 billion.

Cash & Cash Equivalents	6.78B
Total Debt	41.19B
Net Cash	-34.41B
Net Cash Per Share	n/a
Equity (Book Value)	6.43B
Book Value Per Share	11.94
Working Capital	2.65B

Cash Flow

In the last 12 months, operating cash flow was 7.40 billion and capital expenditures -1.38 billion, giving a free cash flow of 6.02 billion.

Operating Cash Flow	7.40B
Capital Expenditures	-1.38B
Depreciation & Amortization	3.73B
Net Borrowing	-4.20B
Free Cash Flow	6.02B
FCF Per Share	n/a

Margins

Gross margin is 70.78%, with operating and profit margins of 31.49% and 20.98%.

Gross Margin	70.78%
Operating Margin	31.49%
Pretax Margin	24.42%
Profit Margin	20.98%
EBITDA Margin	45.22%
EBIT Margin	31.49%
FCF Margin	22.04%

Dividends & Yields

This stock pays an annual dividend of 7.22, which amounts to a dividend yield of 2.08%.

Dividend Per Share	7.22
Dividend Yield	2.08%
Dividend Growth (YoY)	0.46%
Years of Dividend Growth	7
Payout Ratio	66.45%
Buyback Yield	-0.19%
Shareholder Yield	1.90%
Earnings Yield	4.23%
FCF Yield	4.44%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Amgen has an Altman Z-Score of 1.65 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.65
Piotroski F-Score	7